Editing Avacta Group Plc (section)

=== Manufacturing and supply risk - Diagnostics ===
The Group develops, with manufacturing partners, lateral flow tests which require formal clinical validation and CE marking. The Group has identified third-party manufacturing partners and established an appropriate supply chain for the manufacture of approved lateral flow tests. The ability to produce tests within the UK to a cost price which would make tests competitive with Chinese-manufactured tests has been a significant challenge and the Group continues to explore alternative production routes for the manufacture of future tests. The Group has established contractual relationships with several key manufacturers and suppliers of kit components in order to ensure availability of supply and not place overreliance on any one supplier/manufacturer.